| Titolo |
Pubblicato in |
Anno |
| Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy |
JOURNAL OF NEUROINFLAMMATION |
2019 |
| The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system |
NEUROPHARMACOLOGY |
2019 |
| Involvement of the chemokine prokineticin-2 (PROK2) in Alzheimer's disease: from animal models to the human pathology |
CELLS |
2019 |
| HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia |
JOURNAL OF NEUROINFLAMMATION |
2018 |
| PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor |
NEUROPEPTIDES |
2018 |
| The multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain |
MOLECULAR PAIN |
2018 |
| In vitro and in vivo pharmacological activities of 14-o-phenylpropyloxymorphone, a potent mixed mu/delta/kappa-opioid receptor agonist with reduced constipation in mice |
FRONTIERS IN PHARMACOLOGY |
2018 |
| Maternal exposure to low levels of corticosterone during lactation protects adult rat progeny against TNBS-induced colitis: A study on GR-mediated anti-inflammatory effect and prokineticin system |
PLOS ONE |
2017 |
| The prokineticin Bv8 sensitizes cutaneous terminals of female mice to heat |
EUROPEAN JOURNAL OF PAIN |
2016 |
| Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro |
NEUROPHARMACOLOGY |
2016 |
| Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes |
PLOS ONE |
2016 |
| Age-related ultrastructural and monoamine oxidase changes in the rat optic nerve |
JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS |
2016 |
| Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease |
NEUROPHARMACOLOGY |
2016 |
| PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice |
PHARMACOLOGICAL RESEARCH |
2015 |
| Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model |
BIOMED RESEARCH INTERNATIONAL |
2015 |
| N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans. |
MOLECULAR PAIN |
2015 |
| Critical role for prokineticin 2 in CNS autoimmunity |
NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION |
2015 |
| Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity |
SCIENTIFIC REPORTS |
2015 |
| Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice |
MOLECULAR BRAIN |
2015 |
